METTL3 amplifies the translation of SCAP mRNA in NAFLD-HCC, promoting cholesterol biosynthesis while simultaneously impairing the cytotoxic capacity of CD8+ T cells. This evidence concerns the gene CD8A and metabolic dysfunction-associated steatotic liver disease.